Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Nt2innvovate's Profile
Displaying 101-150 of 263 result(s).
CYDY CytoDyn Inc
04/18/2020 4:48:09 PM
Don't pay much attention to conspir (2)
CYDY CytoDyn Inc
04/18/2020 1:10:53 PM
Agree with what you are saying Crai (2)
CYDY CytoDyn Inc
04/18/2020 12:41:56 PM
Just curious. Do most here feel tha (3)
CYDY CytoDyn Inc
04/18/2020 11:46:59 AM
Also, as Dr. Patterson said, leronl (1)
CYDY CytoDyn Inc
04/18/2020 11:43:01 AM
Peacekat this info is good to see. (1)
CYDY CytoDyn Inc
04/18/2020 11:16:55 AM
In fairness, Remdesivir and HCQ as (1)
CYDY CytoDyn Inc
04/18/2020 9:25:53 AM
I believe that emergency approval i
CYDY CytoDyn Inc
04/16/2020 1:40:47 PM
Generally, if a drug is near an FDA
CYDY CytoDyn Inc
04/15/2020 8:13:06 PM
I believe that Actemra (Genentech) (4)
CYDY CytoDyn Inc
04/15/2020 2:26:41 PM
Great question Misiu. I think clari (1)
CYDY CytoDyn Inc
04/15/2020 1:59:56 PM
Azithromycin (Zpak), as with all ma (1)
CYDY CytoDyn Inc
04/14/2020 10:02:41 PM
I believe NP said the primary endpo (4)
CYDY CytoDyn Inc
04/14/2020 8:02:09 PM
Evil. Isn't more reasonable to ask (2)
CYDY CytoDyn Inc
04/14/2020 6:16:28 PM
500k-600k vials divided by 52 weeks
CYDY CytoDyn Inc
04/14/2020 5:22:50 PM
The best way to save the most lives
CYDY CytoDyn Inc
04/14/2020 4:09:16 PM
Triage, are you also referring to y
CYDY CytoDyn Inc
04/14/2020 3:32:13 PM
Relax guys, this the same 500k vial (11)
CYDY CytoDyn Inc
04/14/2020 1:37:52 PM
Media now talking about cheap antip (2)
CYDY CytoDyn Inc
04/14/2020 8:42:23 AM
NP has said Kelly introduced him to (4)
CYDY CytoDyn Inc
04/12/2020 2:08:03 PM
Doc580 and Misiu, I agree fully wit (8)
CYDY CytoDyn Inc
04/12/2020 12:37:26 PM
Conspiracy theories aren't legit he (17)
CYDY CytoDyn Inc
04/12/2020 9:57:00 AM
If the majority are asymptomatic or (2)
CYDY CytoDyn Inc
04/12/2020 9:17:09 AM
Yup. The goals are treatment and bu (2)
CYDY CytoDyn Inc
04/12/2020 8:52:46 AM
Also before anyone starts praising (2)
CYDY CytoDyn Inc
04/12/2020 8:44:21 AM
It because the virus is not contain (3)
CYDY CytoDyn Inc
04/11/2020 6:59:13 AM
It's also interesting that those wi
CYDY CytoDyn Inc
04/11/2020 6:36:22 AM
I heard a rumour a couple of weeks
CYDY CytoDyn Inc
04/10/2020 8:57:00 PM
Is this patient separate from the o
CYDY CytoDyn Inc
04/10/2020 1:58:56 PM
Agree. Great post PNW. It is reason (3)
CYDY CytoDyn Inc
04/05/2020 8:38:39 PM
Maybe POTUS is just using common se (5)
CYDY CytoDyn Inc
04/05/2020 4:44:40 PM
Misiu is on point with everything s (3)
CYDY CytoDyn Inc
03/28/2020 4:23:20 PM
Maybe they will send the blood samp
CYDY CytoDyn Inc
03/28/2020 11:58:35 AM
I believe that Dr. Sacha is working
CYDY CytoDyn Inc
03/28/2020 11:48:13 AM
Dr. Sacha is already working on con
CYDY CytoDyn Inc
03/28/2020 8:44:20 AM
If samples have to be FedExed to IN
CYDY CytoDyn Inc
03/28/2020 8:42:53 AM
NP said the the second group of 3 p
CYDY CytoDyn Inc
03/28/2020 7:36:55 AM
Patterson said that TNF alpha also (3)
CYDY CytoDyn Inc
03/26/2020 2:38:13 PM
It's interesting but I wanted to as
CYDY CytoDyn Inc
03/26/2020 12:30:40 AM
Sounds reasonable misiu. Never actu (1)
CYDY CytoDyn Inc
03/25/2020 11:20:30 PM
What is also interesting to me abou (1)
CYDY CytoDyn Inc
03/25/2020 10:59:59 PM
The impetus for trying HCQ early is (1)
CYDY CytoDyn Inc
03/25/2020 8:26:38 PM
All this talk of HCQ and Z paks bei (3)
CYDY CytoDyn Inc
03/25/2020 3:51:12 PM
If leronlimab works as Patterson ho (4)
CYDY CytoDyn Inc
03/25/2020 1:14:07 PM
Isn't testing a problem with the co (2)
CYDY CytoDyn Inc
03/25/2020 11:59:54 AM
Maybe Mini Mike should be fair and (2)
CYDY CytoDyn Inc
03/25/2020 11:34:24 AM
Maybe they are busy writing themsel (1)
CYDY CytoDyn Inc
03/24/2020 8:31:15 PM
It looks like Actemra by Roche, ano
CYDY CytoDyn Inc
03/24/2020 7:30:59 PM
Good question. He said queuing up f
CYDY CytoDyn Inc
03/24/2020 12:50:03 PM
It may be possible that HCQ/Azithro (3)
CYDY CytoDyn Inc
03/24/2020 12:40:32 PM
HCQ is different from CQ and has a (2)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Cambodia's Techo International Airport: A Gateway to Growth
  • Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
  • Faraday Future's Vision: Accelerating Towards FX Super One Launch
  • IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
  • Clover Biopharmaceuticals Names Nicholas Jackson as President
  • Dr. Luke Wainscoat Brings Expertise to The Brattle Group
  • Kering and L'Oréal Unite to Transform Luxury Beauty Sector
  • Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
  • Kering Partners with L'Oréal to Transform Luxury Beauty Sector
  • Alice Walton and Elon Musk: Giants of Wealth in 2025
  • Clarins and V Magazine Host a Glamorous Golden Hour Event
  • Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
  • Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
  • Exploring NB HASH and the Transformation of Wealth Today
  • Kevin Hart's Journey From Investment Missteps to Business Success
  • BlackRock's Strategic Shift: The Future of Investment in RWA
  • Major Contract Termination Announced by Vantage Drilling
  • Deadline Approaches for Dow Inc. Investors Amid Legal Action
  • Important Update for Cepton, Inc. Investors on Class Action
  • Target and Walmart Thrive Amid Collectible Card Sales Surge
  • Snap Investors Urged to Consider Leading Legal Action
  • Unlocking Wealth Potential: The RWA Revolution Explained
  • Embracing Real-World Assets with NB HASH for Sustainable Growth
  • Nutex Health Investors Can Join Class Action Against Company
  • Potential Legal Action for Baxter International Investors
  • Solidarity in Aviation: Airline Workers Support Controllers
  • Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
  • Promising Outcomes Unveiled from HARMONi-6 Clinical Study
  • Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
  • Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
  • Promising Findings on Subcutaneous Amivantamab for Cancer
  • Vivace Therapeutics Reports Promising Results for VT3989 Therapy
  • iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
  • Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
  • New Breakthrough Data from Novartis on Prostate Cancer Treatment
  • Transforming Assets: The Role of NB HASH in Digital Wealth
  • The Future of Wealth: Bridging Real-World Assets with Blockchain
  • Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
  • Significant Phase 1a Trial Findings for Faridoxorubicin
  • Major Developments in AI: Insights from Top Tech Executives
  • Celebrating Five Years of Innovations at United Imaging's Hub
  • International Engagement Highlighted at Financial Forum 2025
  • Crypto World Buzzes: Ripple's Fund, Bitcoin's Future & More
  • Max Stock Limited Reveals Holdings of Key Parties and Officers
  • China's Revolutionary Advances in Solid-State Battery Tech
  • Biggest Weekly Losers: Insights on IonQ and Tempus AI Stocks
  • Revolutionizing Startup Insight with AI: Startuprad.io's New Tool
  • Revolutionizing Patient Care with AI: HDAI's Innovative Approach
  • Top Gainers in the Market: D-Wave, Estée Lauder & Others
  • Empowering Higher Education Payroll Professionals at EIPC
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site